Our Blog

Noxopharm (ASX:NOX) and the rising interest in radiopharmaceuticals and nuclear medicine

14 Jan 2019 – Noxopharm Limited (ASX:NOX) Managing Director and CEO, Dr Graham Kelly and Associate Professor Louise Emmett, Clinical Director of Theranostics and Nuclear Medicine at St Vincent’s Hospital, Sydney talk about the growing interest in radiopharmaceuticals.

Source: Finance News Network

Share this post